Novel Coronavirus (COVID-19) Physician Tracking Report – Wave 5

Wave 6 of this Tracking Report is now available here!

Since January, InCrowd has been conducting novel coronavirus (COVID-19) tracking research to understand the impact of the pandemic on several US healthcare stakeholder groups. Now in its fifth wave, InCrowd has been monitoring frontline-treating physicians’ perceptions on the spread of the virus, preparedness, a variety of concerns, and how they envision both pharma engagement and care delivery in the future. Discover the latest findings and insights from InCrowd’s most recent wave of COVID-19 physician research.


  • Method: 10-minute MicroSurvey via InCrowd
  • Crowds: US Primary Care Physicians (PCPs), Pediatricians (PEDs), and Emergency Medicine or Critical Care Physicians (EMCCs)
  • Sample Size: n=204
  • Fielding Period: May 29-31, 2020 (Previous Waves: Apr. 14-15, Mar. 19-20, Feb. 26-27, Jan. 31-Feb. 4)

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Why Diversity Matters to Patients

Why Diversity Matters to Patients

How does a diverse patient audience feel about representation among their own physicians? Is the diversity outlook improving among healthcare professionals? Find out in our latest report from the 2023 Pharma Market Research Conference. We examined: Satisfaction with...

read more
ASH 2022 Real-Time Round-Up

ASH 2022 Real-Time Round-Up

The 2022 Annual Meeting of the American Society of Hematology (ASH) took place in person from December 10th to the 13th. InCrowd wanted to learn from those Hematologists and Hematology-Oncologists who attended these two objectives: Explore which condition had the most...

read more